Karen Linehan
Director/Board Member chez VEON LTD.
Fortune : 154 263 $ au 31/03/2024
Postes actifs de Karen Linehan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VEON LTD. | Director/Board Member | 04/01/2022 | - |
| Independent Dir/Board Member | 04/01/2022 | - | |
| AELIS FARMA | Director/Board Member | 01/01/2022 | - |
| Independent Dir/Board Member | 01/01/2022 | - | |
| CNH INDUSTRIAL N.V. | Director/Board Member | 11/03/2022 | - |
| Independent Dir/Board Member | 11/03/2022 | - | |
Hoechst GmbH
 Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The private company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Director/Board Member | - | - |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Director/Board Member | - | - |
Global Antibiotic Research & Development Partnership
 Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Director/Board Member | - | - |
| Georgetown University Law Center | Corporate Officer/Principal | - | - |
Historique de carrière de Karen Linehan
Anciens postes connus de Karen Linehan
Formation de Karen Linehan
| Georgetown University | Graduate Degree |
Statistiques
Internationale
| France | 4 |
| Etats-Unis | 3 |
| Allemagne | 3 |
Opérationnelle
| Director/Board Member | 7 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
| Communications | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SANOFI | Health Technology |
| VEON LTD. | Communications |
| CNH INDUSTRIAL N.V. | Producer Manufacturing |
| AELIS FARMA | Health Technology |
| EUROAPI | Health Technology |
| Entreprise privées | 3 |
|---|---|
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The private company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Health Technology |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Health Technology |
- Bourse
- Insiders
- Karen Linehan
- Expérience
